Interferons‐beta versus glatiramer acetate for relapsing‐remitting multiple sclerosis

BACKGROUND: Interferons‐beta (IFNs‐beta) and glatiramer acetate (GA) were the first two disease‐modifying therapies (DMTs) approved 20 years ago for the treatment of multiple sclerosis (MS). DMTs' prescription rates as first or switching therapies and their costs have both increased substantial...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: La Mantia, Loredana, Di Pietrantonj, Carlo, Rovaris, Marco, Rigon, Giulio, Frau, Serena, Berardo, Francesco, Gandini, Anna, Longobardi, Anna, Weinstock‐Guttman, Bianca, Vaona, Alberto
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2016
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464642/
https://ncbi.nlm.nih.gov/pubmed/27880972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009333.pub3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados